|
ARIH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.695030E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.202660E-04 |
| Normal-vs-Stage2 |
1.876040E-01 |
| Normal-vs-Stage3 |
2.009800E-01 |
| Normal-vs-Stage4 |
9.778200E-01 |
| Stage1-vs-Stage2 |
4.482800E-01 |
| Stage1-vs-Stage3 |
2.150400E-01 |
| Stage1-vs-Stage4 |
3.139000E-01 |
| Stage2-vs-Stage3 |
8.001400E-01 |
| Stage2-vs-Stage4 |
4.887400E-01 |
| Stage3-vs-Stage4 |
6.244800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.857870E-03 |
| Normal-vs-AfricanAmerican |
2.412100E-02 |
| Normal-vs-Asian |
5.744800E-01 |
| Caucasian-vs-AfricanAmerican |
9.263000E-01 |
| Caucasian-vs-Asian |
7.675400E-01 |
| AfricanAmerican-vs-Asian |
7.952200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.57310000000033E-05 |
| Normal-vs-Female |
9.760800E-01 |
| Male-vs-Female |
2.207500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.281600E-02 |
| Normal-vs-Extreme_Weight |
3.32579999995364E-06 |
| Normal-vs-Obese |
1.826190E-01 |
| Normal-vs-Extreme_Obese |
5.135800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.762590E-01 |
| Normal_Weight-vs-Obese |
3.711600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.307000E-01 |
| Extreme_Weight-vs-Obese |
8.664800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.537400E-01 |
| Obese-vs-Extreme_Obese |
2.345800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.922200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.508100E-02 |
| Normal-vs-Age(61-80Yrs) |
5.237000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.98715999999433E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.038000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.858300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.475810E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.537960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.627900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.603440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.564400E-04 |
| Normal-VS-Type2 PRCC |
1.362770E-03 |
| Normal-VS-KIRP CIMP |
1.253030E-01 |
| Normal-VS-Unclassified PRCC |
4.547000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.588600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.042900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.079020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.721660E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.227370E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.402100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.93330000000758E-06 |
| Normal-vs-N1 |
3.473600E-01 |
| Normal-vs-N2 |
9.897600E-01 |
| N0-vs-N1 |
1.440170E-03 |
| N0-vs-N2 |
4.347800E-01 |
| N1-vs-N2 |
7.245200E-01 |
|
|
